Profil
Paul F.
Engler is the founder of Cactus Feeders, Inc. which was founded in 1975, where he holds the title of Chairman.
Currently, he is a Director at Toragen, Inc. since 2022.
In the past, he worked as a Director at GlobeSecNine, Inc.
Aktive Positionen von Paul F. Engler
| Unternehmen | Position | Beginn |
|---|---|---|
Cactus Feeders, Inc.
Cactus Feeders, Inc. Agricultural Commodities/MillingProcess Industries Provides cattle feeding services | Gründer | 01.01.1975 |
Toragen, Inc.
Toragen, Inc. BiotechnologyHealth Technology Engages in developing, repurposing and commercializing cancer drugs | Direktor/Vorstandsmitglied | 15.08.2022 |
Ehemalige bekannte Positionen von Paul F. Engler
| Unternehmen | Position | Ende |
|---|---|---|
GlobeSecNine, Inc.
GlobeSecNine, Inc. Investment ManagersFinance GlobeSecNine invests in both public and private companies located in the United States. The firm targets companies operating in the fields of defense & classified services, port & transportation system security, agriculture, water and food safety sectors. The firm participates in MBOs, consolidations, build-ups and growth capital transactions. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Cactus Feeders, Inc.
Cactus Feeders, Inc. Agricultural Commodities/MillingProcess Industries Provides cattle feeding services | Process Industries |
GlobeSecNine, Inc.
GlobeSecNine, Inc. Investment ManagersFinance GlobeSecNine invests in both public and private companies located in the United States. The firm targets companies operating in the fields of defense & classified services, port & transportation system security, agriculture, water and food safety sectors. The firm participates in MBOs, consolidations, build-ups and growth capital transactions. | Finance |
Toragen, Inc.
Toragen, Inc. BiotechnologyHealth Technology Engages in developing, repurposing and commercializing cancer drugs | Health Technology |
















